3D Global Biotech Inc. (6808.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan · ISIN TW0006808009

Price
30.30 TWD
Market cap
2.33 bn TWD
P/E (2025)
35.06
P/S (2025)
11.28
Dividend yield
0.44 %
Net margin
32.18 %
Return on equity (ROE)
6.76 %
Return on assets (ROA)
6.10 %

3D Global Biotech Inc. financials

Fiscal year20242025
Revenue265.69 m TWD206.74 m TWD
Gross profit174.51 m TWD148.41 m TWD
Operating income88.70 m TWD44.22 m TWD
EBIT96.19 m TWD53.71 m TWD
Net income91.70 m TWD66.53 m TWD
Diluted EPS – continuing operations1.30 TWD0.86 TWD

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About 3D Global Biotech Inc.

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.